These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

507 related articles for article (PubMed ID: 22905868)

  • 1. Two pathogen reduction technologies--methylene blue plus light and shortwave ultraviolet light--effectively inactivate hepatitis C virus in blood products.
    Steinmann E; Gravemann U; Friesland M; Doerrbecker J; Müller TH; Pietschmann T; Seltsam A
    Transfusion; 2013 May; 53(5):1010-8. PubMed ID: 22905868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of Zika virus infectivity in platelet concentrates after treatment with ultraviolet C light and in plasma after treatment with methylene blue and visible light.
    Fryk JJ; Marks DC; Hobson-Peters J; Watterson D; Hall RA; Young PR; Reichenberg S; Tolksdorf F; Sumian C; Gravemann U; Seltsam A; Faddy HM
    Transfusion; 2017 Nov; 57(11):2677-2682. PubMed ID: 28718518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inactivation of Ebola virus and Middle East respiratory syndrome coronavirus in platelet concentrates and plasma by ultraviolet C light and methylene blue plus visible light, respectively.
    Eickmann M; Gravemann U; Handke W; Tolksdorf F; Reichenberg S; Müller TH; Seltsam A
    Transfusion; 2018 Sep; 58(9):2202-2207. PubMed ID: 29732571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inactivation of three emerging viruses - severe acute respiratory syndrome coronavirus, Crimean-Congo haemorrhagic fever virus and Nipah virus - in platelet concentrates by ultraviolet C light and in plasma by methylene blue plus visible light.
    Eickmann M; Gravemann U; Handke W; Tolksdorf F; Reichenberg S; Müller TH; Seltsam A
    Vox Sang; 2020 Apr; 115(3):146-151. PubMed ID: 31930543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inactivation of Japanese encephalitis virus in plasma by methylene blue combined with visible light and in platelet concentrates by ultraviolet C light.
    Rustanti L; Hobson-Peters J; Colmant AMG; Hall RA; Young PR; Reichenberg S; Tolksdorf F; Sumian C; Gravemann U; Seltsam A; Marks DC; Faddy HM
    Transfusion; 2020 Nov; 60(11):2655-2660. PubMed ID: 32830340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inactivation of yellow fever virus in plasma after treatment with methylene blue and visible light and in platelet concentrates following treatment with ultraviolet C light.
    Faddy HM; Fryk JJ; Hall RA; Young PR; Reichenberg S; Tolksdorf F; Sumian C; Gravemann U; Seltsam A; Marks DC
    Transfusion; 2019 Jul; 59(7):2223-2227. PubMed ID: 31050821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inactivation of SARS-CoV-2 infectivity in platelet concentrates or plasma following treatment with ultraviolet C light or with methylene blue combined with visible light.
    Hobson-Peters J; Amarilla AA; Rustanti L; Marks DC; Roulis E; Khromykh AA; Modhiran N; Watterson D; Reichenberg S; Tolksdorf F; Sumian C; Seltsam A; Gravemann U; Faddy HM
    Transfusion; 2023 Feb; 63(2):288-293. PubMed ID: 36573801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inactivation of viruses in platelet and plasma products using a riboflavin-and-UV-based photochemical treatment.
    Keil SD; Bengrine A; Bowen R; Marschner S; Hovenga N; Rouse L; Gilmour D; Duverlie G; Goodrich RP
    Transfusion; 2015 Jul; 55(7):1736-44. PubMed ID: 25731607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenge study of the pathogen reduction capacity of the THERAFLEX MB-Plasma technology.
    Reichenberg S; Gravemann U; Sumian C; Seltsam A
    Vox Sang; 2015 Aug; 109(2):129-37. PubMed ID: 25899343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogen reduction by ultraviolet C light effectively inactivates human white blood cells in platelet products.
    Pohler P; Müller M; Winkler C; Schaudien D; Sewald K; Müller TH; Seltsam A
    Transfusion; 2015 Feb; 55(2):337-47. PubMed ID: 25134439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis E virus is effectively inactivated in platelet concentrates by ultraviolet C light.
    Praditya D; Friesland M; Gravemann U; Handke W; Todt D; Behrendt P; Müller TH; Steinmann E; Seltsam A
    Vox Sang; 2020 Oct; 115(7):555-561. PubMed ID: 32383163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential and limitation of UVC irradiation for the inactivation of pathogens in platelet concentrates.
    Terpstra FG; van 't Wout AB; Schuitemaker H; van Engelenburg FA; Dekkers DW; Verhaar R; de Korte D; Verhoeven AJ
    Transfusion; 2008 Feb; 48(2):304-13. PubMed ID: 18028277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dengue and chikungunya viruses in plasma are effectively inactivated after treatment with methylene blue and visible light.
    Fryk JJ; Marks DC; Hobson-Peters J; Prow NA; Watterson D; Hall RA; Young PR; Reichenberg S; Sumian C; Faddy HM
    Transfusion; 2016 Sep; 56(9):2278-85. PubMed ID: 27456861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. West Nile virus in plasma is highly sensitive to methylene blue-light treatment.
    Mohr H; Knüver-Hopf J; Gravemann U; Redecker-Klein A; Müller TH
    Transfusion; 2004 Jun; 44(6):886-90. PubMed ID: 15157256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis E virus is effectively inactivated by methylene blue plus light treatment.
    Gravemann U; Engelmann M; Kinast V; Burkard T; Behrendt P; Schulze TJ; Todt D; Steinmann E
    Transfusion; 2022 Nov; 62(11):2200-2204. PubMed ID: 36125237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inactivation of dengue, chikungunya, and Ross River viruses in platelet concentrates after treatment with ultraviolet C light.
    Faddy HM; Fryk JJ; Prow NA; Watterson D; Young PR; Hall RA; Tolksdorf F; Sumian C; Gravemann U; Seltsam A; Marks DC
    Transfusion; 2016 Jun; 56(6 Pt 2):1548-55. PubMed ID: 26926832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of increased agitation speed on pathogen inactivation efficacy and in vitro quality in UVC-treated platelet concentrates.
    van der Meer PF; Gravemann U; de Korte D; Sumian C; Tolksdorf F; Müller TH; Seltsam A
    Vox Sang; 2016 Aug; 111(2):127-34. PubMed ID: 27167507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of the THERAFLEX UV-Platelets pathogen inactivation system - an update.
    Seghatchian J; Tolksdorf F
    Transfus Apher Sci; 2012 Apr; 46(2):221-9. PubMed ID: 22365926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the tolerability and immunogenicity of ultraviolet C-irradiated autologous platelets in a dog model.
    Pohler P; Lehmann J; Veneruso V; Tomm J; von Bergen M; Lambrecht B; Kohn B; Weingart C; Müller TH; Seltsam A
    Transfusion; 2012 Nov; 52(11):2414-26. PubMed ID: 22404822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Photodynamic inactivation of model virus in human plasma by methylene blue and its influence on plasma proteins.
    Wang D; Bu F; Xu J
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2000 Mar; 14(1):52-5. PubMed ID: 11503026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.